Mood - Anxiety Disorders & Antidepressants – Mood Stabilizers

(Haga un click en la información del journal para acceder al resúmen)

5 – doble-ciego o metanálisis; 4 – subanálisis o simple ciego; 3 – revisión, abierto, básico; 2 – casos; 1 – opinión

 

3 - Agomelatine Treatment of Major Depressive Disorder

Christian R Dolder, Michael Nelson, Morgan Snider

The Annals of Pharmacotherapy: Vol. 42, No. 12, pp. 1822-1831

 

3! - Meta-Analysis of the Symptom Structure of Obsessive-Compulsive Disorder

Michael H. Bloch, Angeli Landeros-Weisenberger, Maria C. Rosario, Christopher Pittenger, and James F. Leckman

Am J Psychiatry 2008; 165:1532-1542

3! - Plasma Melatonin Circadian Rhythm Disturbances During Pregnancy and Postpartum in Depressed Women and Women With Personal or Family Histories of Depression

Barbara L. Parry, Charles J. Meliska, Diane L. Sorenson, Ana M. Lopez, Luis F. Martinez, Sara Nowakowski, Jeffrey A. Elliott, Richard L. Hauger, and Daniel F. Kripke

Am J Psychiatry 2008; 165:1551-1558

3! - Association Between Major Depressive Disorder and Heart Rate Variability in the Netherlands Study of Depression and Anxiety (NESDA)

Carmilla M. M. Licht, Eco J. C. de Geus, Frans G. Zitman, Witte J. G. Hoogendijk, Richard van Dyck, Brenda W. J. H. Penninx

Arch Gen Psychiatry. 2008;65(12):1358-1367

 

3! - Depressive Symptoms and Change in Abdominal Obesity in Older Persons

Nicole Vogelzangs, Stephen B. Kritchevsky, Aartjan T. F. Beekman, Anne B. Newman, Suzanne Satterfield, Eleanor M. Simonsick, Kristine Yaffe, Tamara B. Harris, Brenda W. J. H. Penninx

Arch Gen Psychiatry. 2008;65(12):1386-1393

 

3! - Incidence and Recurrence of Late-Life Depression

Hendrika J. Luijendijk, Julia F. van den Berg, Marieke J. H. J. Dekker, Hendrik R. van Tuijl, Wim Otte, Filip Smit, Albert Hofman, Bruno H. C. Stricker, Henning Tiemeier

Arch Gen Psychiatry. 2008;65(12):1394-1401

 

3! - Frequency of Painful Physical Symptoms With Major Depressive Disorder in Asia: Relationship With Disease Severity and Quality of Life

Phil Lee, Mingyuan Zhang, Jin Pyo Hong, Hong-Choon Chua, Kuang-Peng Chen, Siu Wa Tang, Benjamin T. M. Chan, Min Soo Lee, Bobbie Lee, Gabrielle L. Gallagher, and Martin Dossenbach

J Clin Psychiatry December 2, 2008: e1-e9

 

3! - Effect of Desvenlafaxine on the Cytochrome P450 2D6 Enzyme System

Preskorn, Sheldon H; Nichols, Alice I; Paul, Jeffrey; Patroneva, Albena L; Helzner, Eileen C; Guico-Pabia, Christine J

Journal of Psychiatric Practice. 14(6):368-378, November 2008

3 - A Critical Examination of Bifrontal Electroconvulsive Therapy: Clinical Efficacy, Cognitive Side Effects, and Directions for Future Research

Crowley, Kevin; Pickle, Jody; Dale, Roman; Fattal, Omar

Journal of ECT. 24(4):268-271, December 2008

3 - Changes in brain function during administration of venlafaxine or placebo to normal subjects
Leuchter AF, Cook IA, DeBrota DJ, Hunter AM, Potter WZ, McGrouther CC, Morgan ML, Abrams M, Siegman B

Clin EEG Neurosci. 2008 Oct;39(4):175-81

 

5 - Does Randomized Evidence Support Sertraline as First-Line Antidepressant for Adults With Acute Major Depression? A Systematic Review and Meta-Analysis

Andrea Cipriani, Toshiaki A. Furukawa, John R. Geddes, Lara Malvini, Alessandra Signoretti, Hugh McGuire, Rachel Churchill, Atsuo Nakagawa, and Corrado Barbui, on behalf of the MANGA Study Group

J Clin Psychiatry 2008;69:1732-1742

 

5 - Olanzapine Versus Divalproex Versus Placebo in the Treatment of Mild to Moderate Mania: A Randomized, 12-Week, Double-Blind Study

Mauricio Tohen, Eduard Vieta, Guy M. Goodwin, Bin Sun, Jay D. Amsterdam, Michael Banov, Anantha Shekhar, Scott T. Aaronson, Leonid Bardenstein, Iosif Grecu-Gaboş, Vladimir Tochilov, Dan Prelipceanu, Heather S. Oliff, Ludmila Kryzhanovskaya, and Charles Bowden

J Clin Psychiatry 2008;69:1776-1789

 

3! - Discontinuation of Maintenance Selective Serotonin Reuptake Inhibitor Monotherapy After 5 Years of Stable Response: A Naturalistic Study

Tara M. Pundiak, Brady G. Case, Eric D. Peselow, and Loretta Mulcare

J Clin Psychiatry 2008;69:1811-1817

 

3! - Are Psychological and Pharmacologic Interventions Equally Effective in the Treatment of Adult Depressive Disorders? A Meta-Analysis of Comparative Studies

Pim Cuijpers, Annemieke van Straten, Patricia van Oppen, and Gerhard Andersson

J Clin Psychiatry 2008;69:1675-1685

 

3! - Functional outcomes in first-episode patients with bipolar disorder: a prospective study from the Systematic Treatment Optimization Program for Early Mania project

Marcia Kauer-Sant'Anna, David J. Bond, Raymond W. Lam and Lakshmi N. Yatham

Comprehensive Psychiatry. Volume 50, Issue 1, January-February 2009, Pages 1-8

 

3! - Sex differences in the phenotypic expression of obsessive-compulsive disorder: an exploratory study from Brazil

Ricardo Cezar Torresan, Ana Teresa de Abreu Ramos-Cerqueira, Maria Alice de Mathis, Juliana Belo Diniz, Ygor Arzeno Ferrão, Euripedes Constantino Miguel and Albina Rodrigues Torres

Comprehensive Psychiatry. Volume 50, Issue 1, January-February 2009, Pages 63-69

 

5! - Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD

George I. Papakostas and Maurizio Fava

European Neuropsychopharmacology. Volume 19, Issue 1, January 2009, Pages 34-40

 

3! - Family History of Depression and Therapeutic Outcome: Findings From STAR*D

Mustafa M. Husain, A. John Rush, Stephen R. Wisniewski, Shawn M. McClintock, Maurizio Fava, Andrew A. Nierenberg, Lori Davis, G. K. Balasubramani, Elizabeth Young, A. Ari Albala, and Madhukar H. Trivedi

J Clin Psychiatry December 2, 2008: e1-e11

 

4 - Adjunctive Aripiprazole in Major Depressive Disorder: Analysis of Efficacy and Safety in Patients With Anxious and Atypical Features

Madhukar H. Trivedi, Michael E. Thase, Maurizio Fava, J. Craig Nelson, Huyuan Yang, Ying Qi, Quynh-Van Tran, Andrei Pikalov, Berit X. Carlson, Ronald N. Marcus, and Robert M. Berman

J Clin Psychiatry December 2, 2008: e1-e9

 

3 - Safety of High-intensity Treatment with the Irreversible Monoamine Oxidase Inhibitor Tranylcypromine in Patients with Treatment-resistant Depression

M. Adli, M. Pilhatsch, M. Bauer, U. Köberle, R. Ricken,G. Janssen, S. Ulrich, T. Bschor

Pharmacopsychiatry 2008; 41: 252-257

5 - Ziprasidone in the treatment of acute mania: a 12-week, placebo-controlled, haloperidol-referenced study

E Vieta, T Ramey, D Keller, PA English, AD Loebel, and J Miceli

Journal of Psychopharmacology. First published on December 12, 2008

3! - Review: paroxetine-induced increase in LDL cholesterol levels

JM Le Melledo, K Mailo, N Lara, MC Abadia, L Gil, M Van Ameringen, G Baker, and J Perez-Parada

Journal of Psychopharmacology. First published on December 12, 2008

3 - Antidepressant-like effect of the organoselenium compound ebselen in mice: Evidence for the involvement of the monoaminergic system

Thaís Posser, Manuella P. Kaster, Sara Cristiane Baraúna, João B.T. Rocha, Ana Lúcia S. Rodrigues and Rodrigo B. Leal

European Journal of Pharmacology. Volume 602, Issue 1, 5 January 2009, Pages 85-91

 

3! - Self-medication of anxiety disorders with alcohol and drugs: Results from a nationally representative sample

Jennifer Robinson, Jitender Sareen, Brian J. Cox and James Bolton

Journal of Anxiety Disorders. Volume 23, Issue 1, January 2009, Pages 38-45

 

3 - Clinical evaluation of paroxetine in post-traumatic stress disorder (PTSD): 52-week, non-comparative open-label study for clinical use experience
Kim Y, Asukai N, Konishi T, Kato H, Hirotsune H, Maeda M, Inoue H, Narita H, Iwasaki M

Psychiatry Clin Neurosci. 2008 Dec;62(6):646-52

 

3 - Sleep disturbances in relation to fatigue in major depression

Panayotis Ferentinos, Vassilis Kontaxakis, Beata Havaki-Kontaxaki, Thomas Paparrigopoulos, Dimitris Dikeos, Periklis Ktonas and Constantin Soldatos

Journal of Psychosomatic Research. Volume 66, Issue 1, January 2009, Pages 37-42

 

3 - Dysbindin gene (DTNBP1) in major depression: association with clinical response to selective serotonin reuptake inhibitors
Arias B, Serretti A, Mandelli L, Gastó C, Catalán R, Ronchi DD, Fañanás L

Pharmacogenet Genomics. 2008 Dec 5. [Epub ahead of print]

 

5 - Comparison of carbamazepine and lithium in treatment of bipolar disorder: A systematic review of randomized controlled trials

Daniela Ceron-Litvoc, Bernardo Garcia Soares, John Geddes, Julio Litvoc, Mauricio Silva de Lima

Human Psychopharmacology: Clinical and Experimental. Published Online: 3 Dec 2008

 

3 - Desvenlafaxine succinate for major depressive disorder: a critical review of the evidence

Jayesh Kamath and Venkatesh Handratta

Expert Review of Neurotherapeutics. December 2008, Vol. 8, No. 12, Pages 1787-1797

 

3! - Depression symptoms during pregnancy

Manber, Christine Blasey, and John J. B. Allen

Archives of Women's Mental Health 11, pp. 43–48, 2008

 

3! - The effects of depression on diabetes knowledge, diabetes self-management, and perceived control in indigent patients with type 2 diabetes

Egede and Ellis

Diabetes Technology & Therapeutics 2008; 10(3), pp. 213-219

 

3! - National patterns in antidepressant treatment by psychiatrists and general medical providers: Results from the National Comorbidity Survey Replication

Ramin Mojtabai, and Mark Olfson

Journal of Clinical Psychiatry 2008; 69(7), pp. 1064-1074

 

3! - Predictors of first lifetime episodes of major depression in midlife women

J. T. Bromberger, H. M. Kravitz, K. Matthews, A. Youk, C. Brown and W. Feng

Psychological Medicine (2009), 39:55-64

 

5 - Antidepressant efficacy of high-frequency transcranial magnetic stimulation over the left dorsolateral prefrontal cortex in double-blind sham-controlled designs: a meta-analysis

D. J. L. G. Schutter

Psychological Medicine (2009), 39:65-75

 

3 - Sleep disturbances in relation to fatigue in major depression

Panayotis Ferentinos, Vassilis Kontaxakis, Beata Havaki-Kontaxaki, Thomas Paparrigopoulos, Dimitris Dikeos, Periklis Ktonas, Constantin Soldatos

J Psychosom Res. Volume 66, Issue 1, Pages 37-42 (January 2009)

 

3! - Common genetic, clinical, demographic and psychosocial predictors of response to pharmacotherapy in mood and anxiety disorders

Serretti, Alessandro; Chiesa, Alberto; Calati, Raffaella; Perna, Giampaolo; Bellodi, Laura; De Ronchi, Diana

International Clinical Psychopharmacology. 24(1):1-18, January 2009

5 - Simultaneous initiation (coinitiation) of pharmacotherapy with triiodothyronine and a selective serotonin reuptake inhibitor for major depressive disorder: a quantitative synthesis of double-blind studies

Papakostas, George I; Cooper-Kazaz, Rena; Appelhof, Bente C; Posternak, Michael A; Johnson, Daniel P; Klibanski, Anne; Lerer, Bernard; Fava, Maurizio

International Clinical Psychopharmacology. 24(1):19-25, January 2009

3 - Pregabalin augmentation of antidepressants in patients with accident-related posttraumatic stress disorder: an open label pilot study

Pae, Chi-Un; Marks, David M. Han, Changsu; Masand, Prakash S; Patkar, Ashwin A

International Clinical Psychopharmacology. 24(1):29-33, January 2009

3! - Salivary Cortisol Levels in Brazilian Citizens of Distinct Socioeconomic and Cultural Levels

Márcia C. Garcia, Aglecio de Souza, Geruza P. Bella, Dora M. Grassi-Kassisse, Artur P. Tacla, and Regina C. Spadari-Bratfisch

Annals of the New York Academy of Sciences. Volume 1148 Issue, Pages 504 - 508

 

3 - Differential Effects of the New Glucocorticoid Receptor Antagonist ORG 34517 and RU486 (Mifepristone) on Glucocorticoid Receptor Nuclear Translocation in the AtT20 Cell Line

B.W.M.M. Peeters, G.S.F. Ruigt, M. Craighead, and P. Kitchener

Annals of the New York Academy of Sciences. Volume 1148 Issue, Pages 536 - 541

 

5 - Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression

Eileen Brown, David L. Dunner, Susan L. McElroy, Paul E. Keck, David H. Adams, Elisabeth Degenhardt, Mauricio Tohen and John P. Houston

The International Journal of Neuropsychopharmacology,Published online 11 Dec 2008

 

3! - Steady-State Concentrations of Mirtazapine, N-Desmethylmirtazapine, 8-Hydroxymirtazapine and their Enantiomers in Relation to Cytochrome P450 2D6 Genotype, Age and Smoking Behaviour
Lind AB, Reis M, Bengtsson F, Jonzier-Perey M, Powell Golay K, Ahlner J, Baumann P, Dahl ML

Clin Pharmacokinet. 2009;48(1):63-70

 

4 - Onset of activity and time to response on individual CAPS-SX₁₇ items in patients treated for post-traumatic stress disorder with venlafaxine ER: a pooled analysis

Dan J. Stein, Ron Pedersen, Barbara O. Rothbaum, David S. Baldwin, Saeeduddin Ahmed, Jeff Musgnung and Jonathan Davidson

The International Journal of Neuropsychopharmacology (2009), 12:23-31

 

3 - Role of serotonin 5-HT_1A receptors in the antidepressant-like effect and the antinociceptive effect of venlafaxine in mice

Esther Berrocoso and Juan A. Mico

The International Journal of Neuropsychopharmacology (2009), 12:61-71

 

3 - Fracture risks of antidepressants

Peter Vestergaard

Expert Review of Neurotherapeutics. January 2009, Vol. 9, No. 1, Pages 137-141

 

5 - Comparison of carbamazepine and lithium in treatment of bipolar disorder: A systematic review of randomized controlled trials

Daniela Ceron-Litvoc , Bernardo Garcia Soares, John Geddes, Julio Litvoc, Mauricio Silva de Lima

Human Psychopharmacology: Clinical and Experimental. Volume 24 Issue 1, Pages 19 - 28

 

5< - St. John's wort and Kava in treating major depressive disorder with comorbid anxiety: a randomised double-blind placebo-controlled pilot trial

Jerome Sarris, David J. Kavanagh, Gary Deed, Kerry M. Bone

Human Psychopharmacology: Clinical and Experimental. Volume 24 Issue 1, Pages 41 - 48

 

GRATIS 3 - Venlafaxine extended release for climacteric women with depression or anxiety diagnosis. An open-label study
Iglesias C, Pato E, Ocio S, Ortigosa J, Santamarina S, Merino M, Alonso M, Fernández L, Alonso J, Rodríguez L

Actas Esp Psiquiatr. 2008 Dec 15. [Epub ahead of print]

 

3 - Nicotine, but not mecamylamine, enhances antidepressant-like effects of citalopram and reboxetine in the mouse forced swim and tail suspension tests

Jesper T. Andreasen and John P. Redrobe

Behavioural Brain Research. Volume 197, Issue 1, 30 January 2009, Pages 150-156

 

3! - The ratio of cortisol/DHEA in treatment resistant depression

Kalypso Markopoulou, Andrew Papadopoulos, Mario F. Juruena, Lucia Poon, Carmine M. Pariante and Anthony J. Cleare

Psychoneuroendocrinology. Volume 34, Issue 1, January 2009, Pages 19-26

 

3! - HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients

E.B. Binder, H.E. Künzel, T. Nickel, N. Kern, A. Pfennig, M. Majer, M. Uhr, M. Ising and F. Holsboer

Psychoneuroendocrinology. Volume 34, Issue 1, January 2009, Pages 99-109

 

3 - Effect of aripiprazole on self-reported anhedonia in bipolar depressed patients

Marianna Mazza, Maria Rosaria Squillacioti, Riccardo Daniele Pecora, Luigi Janiri and Pietro Bria

Psychiatry Research. Volume 165, Issues 1-2, 30 January 2009, Pages 193-196

 

5 - A randomized, placebo-controlled trial of risperidone augmentation for patients with difficult-to-treat unipolar, non-psychotic major depression

Gabor I. Keitner, Steven J. Garlow, Christine E. Ryan, Philip T. Ninan, David A. Solomon, Charles B. Nemeroff and Martin B. Keller

Journal of Psychiatric Research. Volume 43, Issue 3, January 2009, Pages 205-214

 

3! - Clinical characteristics and treatment outcome in a representative sample of depressed inpatients – Findings from the Munich Antidepressant Response Signature (MARS) project

Johannes M. Hennings, Toshimi Owashi, Elisabeth B. Binder, Sonja Horstmann, Andreas Menke, Stefan Kloiber, Tatjana Dose, Bastian Wollweber, Derek Spieler, Thomas Messer, Rita Lutz, Heike Künzel, Thomas Bierner, Thomas Pollmächer, Hildegard Pfister, Thomas Nickel, Annette Sonntag, Manfred Uhr, Marcus Ising, Florian Holsboer and Susanne Lucae

Journal of Psychiatric Research. Volume 43, Issue 3, January 2009, Pages 215-229

 

3! - Substance use disorders and suicide attempts in bipolar subtypes

M. Elizabeth Sublette, Juan J. Carballo, Carmen Moreno, Hanga C. Galfalvy, David A. Brent, Boris Birmaher, J. John Mann and Maria A. Oquendo

Journal of Psychiatric Research. Volume 43, Issue 3, January 2009, Pages 230-238

 

3! - Mental disorders and cardiovascular disease among adults in the United States

Renee D. Goodwin, Karina W. Davidson and Katherine Keyes

Journal of Psychiatric Research. Volume 43, Issue 3, January 2009, Pages 239-246

 

3 - Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine

Francesco Matrisciano, Stefania Bonaccorso, Angelo Ricciardi, Sergio Scaccianoce, Isabella Panaccione, Lily Wang, Amedo Ruberto, Roberto Tatarelli, Ferdinando Nicoletti, Paolo Girardi and Richard C. Shelton

Journal of Psychiatric Research. Volume 43, Issue 3, January 2009, Pages 247-254

 

3 - Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression: A randomized, placebo-controlled study

Gwenn S. Smith, Charles F. Reynolds III, Patricia R. Houck, Mary Amanda Dew, Joshua Ginsberg, Yilong Ma, Benoit H. Mulsant and Bruce G. Pollock

Psychiatry Research: Neuroimaging. Volume 171, Issue 1, 30 January 2009, Pages 1-9

 

3! - Unfaithful neurotransmitter transporters: Focus on serotonin uptake and implications for antidepressant efficacy

Lynette C. Daws

Pharmacology & Therapeutics. Volume 121, Issue 1, January 2009, Pages 89-99

 

3 - Long-lasting behavioural and molecular alterations induced by early postnatal fluoxetine exposure are restored by chronic fluoxetine treatment in adult mice

Nina N. Karpova, Jesse Lindholm, Priit Pruunsild, Tõnis Timmusk and Eero Castrén

European Neuropsychopharmacology. Volume 19, Issue 2, February 2009, Pages 97-108

 

3! - Dual- and Triple-Acting Agents for Treating Core and Co-morbid Symptoms of Major Depression: Novel Concepts, New Drugs

Mark J. Millan

Neurotherapeutics. Volume 6, Issue 1, January 2009, Pages 53-77

3! - Response to a Selective Serotonin Reuptake Inhibitor (Citalopram) in Major Depressive Disorder With Melancholic Features: A STAR*D Report

Patrick J. McGrath, Ahsan Y. Khan, Madhukar H. Trivedi, Jonathan W. Stewart, David W. Morris, Stephen R. Wisniewski, Sachiko Miyahara, Andrew A. Nierenberg, Maurizio Fava, and A. John Rush

J Clin Psychiatry 2008;69:1847-1855

 

3! - Long-Term Effectiveness of Lithium in Bipolar Disorder: A Multicenter Investigation of Patients With Typical and Atypical Features

 

Anne Berghöfer, Martin Alda, Mazda Adli, Christopher Baethge, Michael Bauer, Tom Bschor, Tasha Glenn, Paul Grof, Bruno Müller-Oerlinghausen, Janusz Rybakowski, Alexandra Suwalska, and Andrea Pfennig

J Clin Psychiatry 2008;69:1860-1868

 

3! - The Impact of Reboxetine and Mirtazapine on Driving Simulator Performance and Psychomotor Function in Depressed Patients

Alexander Brunnauer, Gerd Laux, Irmgard David, Mirijam Fric, Igor Hermisson, and Hans-Jürgen Möller

J Clin Psychiatry 2008;69:1880-1886

 

3! - Treatment Failure With a Tricyclic Antidepressant Followed by Lithium Addition and Response to Subsequent Electroconvulsive Therapy

Willemijn T. C. Heijnen, Walter W. van den Broek, and Tom K. Birkenhäger

J Clin Psychiatry 2008;69:1887-1891

 

3! - A Prospective Observational Study of Obesity, Body Composition, and Insulin Resistance in 18 Women With Bipolar Disorder and 17 Matched Control Subjects

Sara B. Fleet-Michaliszyn, Isabella Soreca, Amy D. Otto, John M. Jakicic, Andrea Fagiolini, David J. Kupfer, and Bret H. Goodpaster

J Clin Psychiatry 2008;69:1892-1900

 

5 - Adjunctive Aripiprazole in Major Depressive Disorder: Analysis of Efficacy and Safety in Patients With Anxious and Atypical Features

Madhukar H. Trivedi, Michael E. Thase, Maurizio Fava, J. Craig Nelson, Huyuan Yang, Ying Qi, Quynh-Van Tran, Andrei Pikalov, Berit X. Carlson, Ronald N. Marcus, and Robert M. Berman

J Clin Psychiatry 2008;69:1928-1936

 

5< - A 6-Month, Double-Blind, Maintenance Trial of Lithium Monotherapy Versus the Combination of Lithium and Divalproex for Rapid-Cycling Bipolar Disorder and Co-Occurring Substance Abuse or Dependence

David E. Kemp, Keming Gao, Stephen J. Ganocy, Omar Elhaj, Sarah R. Bilali, Carla Conroy, Robert L. Findling, and Joseph R. Calabrese

J Clin Psychiatry December 30, 2008: e1-e9

 

3 - Serotonin Transporter Gene Status and Electroconvulsive Therapy Outcomes: A Retrospective Analysis of 83 Patients

Keith G. Rasmussen, and John L. Black III

J Clin Psychiatry December 30, 2008: e1-e3

 

3! - Predictors of Nonadherence to Continuation and Maintenance Antidepressant Medication in Patients With Remitted Recurrent Depression

Mascha C. ten Doesschate, Claudi L. H. Bockting, Maarten W. J. Koeter, and Aart H. Schene

J Clin Psychiatry December 30, 2008: e1-e7

 

3! - Incidence and predictors of activation syndrome induced by antidepressants

Tsuyoto Harada, Kaoru Sakamoto, Jun Ishigooka

Depression and Anxiety. Volume 25 Issue 12, Pages 1014 - 1019

 

3 - Implications of comorbid alcohol dependence among individuals with social anxiety disorder

Julia D. Buckner, Kiara R. Timpano, Michael J. Zvolensky, Natalie Sachs-Ericsson, Norman B. Schmidt

Depression and Anxiety. Volume 25 Issue 12, Pages 1028 - 1037

 

3 - Family History of Alcohol Dependence and Initial Antidepressant Response to an N-methyl-D-aspartate Antagonist

Laura E. Phelps, Nancy Brutsche, Jazmin R. Moral, David A. Luckenbaugh, Husseini K. Manji and Carlos A. Zarate Jr

Biological Psychiatry. Volume 65, Issue 2, 15 January 2009, Pages 181-184

3! - A multicenter study of major depressive disorder among emergency department patients in Latin-American countries

Ruby C. Castilla-Puentes, Ricardo Secin, Arturo Grau, Roxanna Galeno, Marcelo Feijo de Mello, Nuri Peña, Carlos A. Sanchez-Russi

Depression and Anxiety. Volume 25 Issue 12, Pages E199 - E204

 

3! - Escitalopram in the treatment of major depressive disorder in primary-care settings: an open-label trial

Pratap Chokka, Mark Legault

Depression and Anxiety. Volume 25 Issue 12, Pages E173 - E181

 

3! - A PET Study of Tiagabine Treatment Implicates Ventral Medial Prefrontal Cortex in Generalized Social Anxiety Disorder

Karleyton C Evans, Naomi M Simon, Darin D Dougherty, Elizabeth A Hoge, John J Worthington, Candice Chow, Rebecca E Kaufman, Andrea L Gold, Alan J Fischman, Mark H Pollack and Scott L Rauch

Neuropsychopharmacology (2009) 34, 390–398

 

3! - Glucocorticoid Receptor Antagonism Augments Fluoxetine-Induced Downregulation of the 5-HT Transporter

Daniel Anthony Johnson, Colin David Ingram, Emma Jane Grant, Mark Craighead and Sarah Elizabeth Gartside

Neuropsychopharmacology (2009) 34, 399–409

 

3 - Daily Left Prefrontal Repetitive Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: Clinical Predictors of Outcome in a Multisite, Randomized Controlled Clinical Trial

Sarah H Lisanby, Mustafa M Husain, Peter B Rosenquist, Daniel Maixner, Rosben Gutierrez, Andrew Krystal, William Gilmer, Lauren B Marangell, Scott Aaronson, Zafiris J Daskalakis, Randolph Canterbury, Elliott Richelson, Harold A Sackeim and Mark S George

Neuropsychopharmacology (2009) 34, 522–534

 

3! - The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons

S Yasuda, M-H Liang, Z Marinova, A Yahyavi and D-M Chuang

Molecular Psychiatry (2009) 14, 51–59

 

GRATIS 3! - Pharmacogenetics of selective serotonine reuptake inhibitors: a review

SILVA, Diana Klanovicz and ANDRADE, Fabiana Michelsen de

Rev. psiquiatr. Rio Gd. Sul [online]. 2008, v. 30, n. 1, suppl

 

GRATIS 3! - Basal Thyrotropin and Major Depression: Relation to Clinical Variables and Treatment Outcome

Russell T Joffe, Anthony J Levitt

Can J Psychiatry 2008;53(12):833–838

 

GRATIS 3! - Improving the Prediction of Treatment Response in Depression: Integration of Clinical, Cognitive, Psychophysiological, Neuroimaging, and Genetic Measures

Andrew H. Kemp, Evian Gordon, A. John Rush, and Leanne M. Williams

CNS Spectr. 2008;13(12):1066-1086

.

Regresar a RESÚMENES DICIEMBRE 2008